[Head and neck cancer in the elderly-current aspects].
Tumorerkrankungen des Kopf-Hals-Bereichs im höheren Lebensalter – aktuelle Aspekte.
Aged
Algorithms
Geriatric assessment
Head and neck neoplasms
Multimorbidity
Journal
HNO
ISSN: 1433-0458
Titre abrégé: HNO
Pays: Germany
ID NLM: 2985099R
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
pubmed:
9
1
2020
medline:
3
3
2020
entrez:
9
1
2020
Statut:
ppublish
Résumé
The treatment of head and neck cancer is dominated by surgery and radiochemotherapy, which is in part associated with high morbidity. In elderly patients, however, the otorhinolaryngologist often has to question the rationality of invasive treatment. Although the proportion of geriatric patients with head and neck tumors is increasing, the paucity of data means that there are few consistent standards and recommendations in the literature and guidelines. The aim of this paper is to provide concrete clinical recommendations for geriatric patients with head and neck tumors based on a systematic literature search. A keyword-based literature search was performed to present the current level of evidence and provide a clinical algorithm. In addition to age, the pretreatment dispositional evaluation of geriatric patients should include psychosocial, functional, and medical (patient history) comorbidities. For pretreatment risk stratification, an algorithm was created on the basis of these data for individual evaluation of the patient's pretreatment risk. Pretreatment risk stratification of geriatric patients with head and neck malignancies is of high relevance for the individual decision for or against invasive treatment, but the currently available evidence is limited. This paper is based on a systematic literature review and provides a clinical algorithm for otorhinolaryngologists and head and neck surgeons.
Sections du résumé
BACKGROUND
BACKGROUND
The treatment of head and neck cancer is dominated by surgery and radiochemotherapy, which is in part associated with high morbidity. In elderly patients, however, the otorhinolaryngologist often has to question the rationality of invasive treatment. Although the proportion of geriatric patients with head and neck tumors is increasing, the paucity of data means that there are few consistent standards and recommendations in the literature and guidelines.
OBJECTIVE
OBJECTIVE
The aim of this paper is to provide concrete clinical recommendations for geriatric patients with head and neck tumors based on a systematic literature search.
MATERIALS AND METHODS
METHODS
A keyword-based literature search was performed to present the current level of evidence and provide a clinical algorithm.
RESULTS
RESULTS
In addition to age, the pretreatment dispositional evaluation of geriatric patients should include psychosocial, functional, and medical (patient history) comorbidities. For pretreatment risk stratification, an algorithm was created on the basis of these data for individual evaluation of the patient's pretreatment risk.
CONCLUSION
CONCLUSIONS
Pretreatment risk stratification of geriatric patients with head and neck malignancies is of high relevance for the individual decision for or against invasive treatment, but the currently available evidence is limited. This paper is based on a systematic literature review and provides a clinical algorithm for otorhinolaryngologists and head and neck surgeons.
Identifiants
pubmed: 31912168
doi: 10.1007/s00106-019-00792-1
pii: 10.1007/s00106-019-00792-1
doi:
Types de publication
Journal Article
Systematic Review
Langues
ger
Sous-ensembles de citation
IM
Pagination
184-190Références
Radiother Oncol. 2009 Dec;93(3):516-23
pubmed: 19699545
Br J Oral Maxillofac Surg. 2018 Nov;56(9):830-834
pubmed: 30293807
Plast Reconstr Surg. 2005 Nov;116(6):1659-68; discussion 1669-71
pubmed: 16267429
Langenbecks Arch Surg. 2013 Oct;398(7):947-55
pubmed: 23974916
Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):46-51
pubmed: 20395066
Cancer Surv. 1994;19-20:5-21
pubmed: 7895222
Crit Rev Oncol Hematol. 2008 Apr;66(1):75-83
pubmed: 18164209
Radiother Oncol. 1997 May;43(2):181-8
pubmed: 9192965
Head Neck. 2019 Aug;41(8):2477-2483
pubmed: 30816619
Can Geriatr J. 2014 Sep 05;17(3):83-7
pubmed: 25232366
Otolaryngol Clin North Am. 2018 Aug;51(4):741-751
pubmed: 29801920
Arch Otolaryngol Head Neck Surg. 2001 Sep;127(9):1089-92
pubmed: 11556858
Cancer Treat Rev. 2009 Oct;35(6):487-92
pubmed: 19481353
Eur Arch Otorhinolaryngol. 2005 Jan;262(1):21-6
pubmed: 15014947
Head Neck Oncol. 2011 Jan 06;3:2
pubmed: 21211041
Oral Oncol. 2010 Feb;46(2):92-5
pubmed: 20036609
CA Cancer J Clin. 1997 Jan-Feb;47(1):5-27
pubmed: 8996076
Eur J Cancer. 2015 Oct;51(15):2130-2143
pubmed: 26421817
Eur J Cancer. 1996 Nov;32A(12):2075-81
pubmed: 9014748
Br J Cancer. 2003 Sep 15;89(6):1022-7
pubmed: 12966419
J Geriatr Oncol. 2019 Jul;10(4):577-583
pubmed: 30497979
Surg Oncol. 2004 Dec;13(4):249-55
pubmed: 15615663
Laryngoscope. 2008 Mar;118(3):428-32
pubmed: 18043491
Rep Pract Oncol Radiother. 2012 Aug 10;18(1):16-25
pubmed: 24381743